These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 38353886)

  • 1. Gonadal dysfunction in women with diabetes mellitus.
    Zaimi M; Michalopoulou O; Stefanaki K; Kazakou P; Vasileiou V; Psaltopoulou T; Karagiannakis DS; Paschou SA
    Endocrine; 2024 Aug; 85(2):461-472. PubMed ID: 38353886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of severity of menstrual dysfunction with hyperinsulinemia and dysglycemia in polycystic ovary syndrome.
    Ezeh U; Pisarska MD; Azziz R
    Hum Reprod; 2022 Mar; 37(3):553-564. PubMed ID: 35048126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome.
    Panidis D; Tziomalos K; Chatzis P; Papadakis E; Delkos D; Tsourdi EA; Kandaraki EA; Katsikis I
    Eur J Endocrinol; 2013 Feb; 168(2):145-52. PubMed ID: 23109645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
    Ezeh U; Ezeh C; Pisarska MD; Azziz R
    Fertil Steril; 2021 Jun; 115(6):1557-1568. PubMed ID: 33602559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.
    West S; Lashen H; Bloigu A; Franks S; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Morin-Papunen L
    Hum Reprod; 2014 Oct; 29(10):2339-51. PubMed ID: 25085801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Female reproduction and type 1 diabetes: from mechanisms to clinical findings.
    Codner E; Merino PM; Tena-Sempere M
    Hum Reprod Update; 2012; 18(5):568-85. PubMed ID: 22709979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility issues in women with diabetes.
    Livshits A; Seidman DS
    Womens Health (Lond); 2009 Nov; 5(6):701-7. PubMed ID: 19863473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescent menstrual irregularity.
    Mansfield MJ; Emans SJ
    J Reprod Med; 1984 Jun; 29(6):399-410. PubMed ID: 6379175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity.
    Legro RS; Bentley-Lewis R; Driscoll D; Wang SC; Dunaif A
    J Clin Endocrinol Metab; 2002 May; 87(5):2128-33. PubMed ID: 11994352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.
    Ovalle F; Azziz R
    Fertil Steril; 2002 Jun; 77(6):1095-105. PubMed ID: 12057712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the PCOS phenotype with age.
    Hsu MI
    Steroids; 2013 Aug; 78(8):761-6. PubMed ID: 23624031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Life-cycle management of polycystic ovary syndrome].
    Xu Y
    Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(14):1011-1015. PubMed ID: 37032149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty.
    Otto-Buczkowska E; Grzyb K; Jainta N
    Pediatr Endocrinol Diabetes Metab; 2018; 24(1):40-44. PubMed ID: 30083660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The latest reports and treatment methods on polycystic ovary syndrome.
    Stańczak NA; Grywalska E; Dudzińska E
    Ann Med; 2024 Dec; 56(1):2357737. PubMed ID: 38965663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical implications of polycystic ovary syndrome].
    Dravecká I
    Vnitr Lek; 2016; 62(5):392-7. PubMed ID: 27319232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome.
    Li X; Yang J; Blockeel C; Lin M; Tian X; Wu H; Cao Y; Deng L; Zhou X; Xie J; Hu Y; Chen X
    Acta Obstet Gynecol Scand; 2024 Aug; 103(8):1606-1614. PubMed ID: 38715377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of polycystic ovary syndrome and its clinical and hormonal profile in young females with type 1 diabetes mellitus: experience from a teaching institution of India.
    Dominic N; Sharma L; Mohindra N; Dabadghao P
    Endocrine; 2023 Nov; 82(2):303-310. PubMed ID: 37615813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.